The Boston Project
Login
  • All
  • Breaking News
  • Good News
  • Entertainment
  • Local News
  • World News
  • Human Interest
  • Crisis & Emergency
  • Newsss
  • Politics
  • Technology
  • Business
  • Science
  • Health
  • Security
  • Education
  • Society
  • Environment
  • Infrastructure
  • Law
  • Front Page
» Politics » Permalink » Source
0

STAT+: Medicare chief says TrumpRx is meant to be narrow in scope

Today's biotech news includes the Medicare director offering a tempered view of TrumpRx and high-dose Wegovy getting an FDA nod.
(0) Comments 0 💬
Avatar of Anonymous
Anonymous
3 hrs ago
Search
Say Something
Select the appropriate category for your post.
Add a link to share with the community.
Add a title to make your post stand out.
Share your thoughts with the community.

Trending Today

Drug development is booming in China. Should the U.S. view it as a threat or an opportunity?
Score: 0 Posted by Joe S moments ago
STAT+: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says
Score: 0 Posted by Anonymous moments ago
STAT+: Political influence ‘a serious problem’ for FDA under Trump, former commissioner says
Score: 0 Posted by Alessandro C moments ago
STAT+: Novartis picks up experimental breast cancer therapy for $2B
Score: 0 Posted by Jrussell moments ago
STAT+: Sepsis hospitalizations have tripled in Massachusetts. Is it real or a billing game?
Score: 0 Posted by Lylerocker33 1 mins ago
About Contact Site Map